STOCK TITAN

Bayer Aktien Stock Price, News & Analysis

BAYRY OTC

Welcome to our dedicated page for Bayer Aktien news (Ticker: BAYRY), a resource for investors and traders seeking the latest updates and insights on Bayer Aktien stock.

BAYER AG S/ADR (BAYRY) news covers developments at Bayer AG, a global life science enterprise active in health care and nutrition. Company communications highlight updates across its Pharmaceuticals Division, radiology business and crop science activities, giving investors and observers insight into how Bayer advances its pipeline and product portfolio.

Recent pharmaceutical news emphasizes growth in oncology, cardiology, neurology, immunology and women’s health. Examples include updates on asundexian for secondary stroke prevention, finerenone (Kerendia) in cardiovascular-kidney-metabolic conditions, and oncology assets such as Nubeqa for prostate cancer, Hyrnuo for HER2-mutant non-small cell lung cancer, and Xofigo for metastatic castration-resistant prostate cancer with bone metastases. Bayer also reports on Lynkuet, a hormone-free treatment for moderate to severe hot flashes due to menopause, and a Phase III SUNFLOWER study evaluating Mirena for nonatypical endometrial hyperplasia.

News items also describe Bayer’s work in radiology and molecular imaging, including the low-dose MRI contrast agent gadoquatrane and the acquisition of investigational tracers AT-01 and AT-05 for diagnosing cardiac amyloidosis. Additional coverage highlights cell and gene therapy programs for Parkinson’s disease and ophthalmic conditions, as well as collaborations such as the agreement with Soufflé Therapeutics to develop a heart-targeted siRNA therapy for a form of dilated cardiomyopathy.

On the agriculture side, Bayer Crop Science Canada announcements feature launches like Sivanto Energy for flea beetle control in canola and EverGol Rise for pulse disease control. Together, these updates illustrate how Bayer seeks to execute its mission “Health for all, Hunger for none” through pharmaceutical innovation, diagnostic imaging advances and crop protection solutions.

Rhea-AI Summary

The global biorational market is projected to reach USD 29.93 billion by 2032, growing at a CAGR of 20.7%. This growth is driven by the increasing demand for biorational therapies in crop production to combat pests effectively. Biorationals, including biological pesticides, are noted for their environmental safety and low toxicity to humans. The report highlights that botanicals will dominate revenue shares, with fruits and vegetables leading demand. Moreover, Asia Pacific is experiencing the fastest revenue growth, largely due to rising consumer demand in China and India.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
none
-
Rhea-AI Summary

Consumer Edge has appointed Mitch Barns to its Board of Directors, effective immediately. Barns, former CEO of Nielsen, brings extensive experience in data and analytics, aligning well with Consumer Edge's growth vision. His tenure at Nielsen included managing over $6 billion in revenue. The appointment follows a recent equity financing round that raised over $60 million from CoVenture, aimed at bolstering the company’s growth initiatives. Consumer Edge specializes in consumer insights and analytics to enhance strategic decision-making for stakeholders in diverse corporate landscapes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
management
-
Rhea-AI Summary

Corteva, Inc. (NYSE: CTVA) reported its fourth quarter and full-year 2022 results, highlighting net sales of $3.83 billion for Q4, a 10% increase year-over-year. However, the company faced a loss from continuing operations of $(41) million for Q4 and $1.22 billion for FY 2022, reflecting declines of 33% and 32% respectively. Full-year net sales rose 11% to $17.46 billion, with an operating EBITDA of $3.22 billion and operating EPS of $2.67. Guidance for 2023 estimates net sales between $18.1 billion and $18.4 billion, marking a 5% growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
Rhea-AI Summary

Salesforce (NYSE: CRM) announced new appointments to its Board of Directors, effective March 1, 2023.

  • Arnold Donald, former President and CEO of Carnival Corporation
  • Sachin Mehra, CFO of Mastercard
  • Mason Morfit, CEO of ValueAct Capital

This move is part of Salesforce's strategy for board refreshment aimed at enhancing leadership. Outgoing directors Sanford Robertson and Alan Hassenfeld will not seek re-election. CEO Marc Benioff welcomed the new members, highlighting their diverse expertise to foster continued growth for Salesforce, a company valued at approximately $150 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
management
-
Rhea-AI Summary

Bayer has appointed Ben Kampelman, previously Director of Strategic Communications for Crop Science North America, as the new Vice President of Communications for the Crop Science division in North America. In this role, Kampelman will oversee all corporate communications activities, focusing on corporate reputation and media relations. With over 20 years of experience at Bayer and its predecessor Monsanto, he brings extensive industry knowledge. This leadership change is expected to enhance Bayer's communication strategies in North America, supporting its vision of Health for All, Hunger for None. Kampelman assumed his role in November 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
management
-
Rhea-AI Summary

ONIT Sciences announced that Eric Mathur, a distinguished plant geneticist and molecular biologist, has been appointed as the company’s Chief Science Officer. With over 40 years of experience, Mathur has expertise in genome sciences, molecular biology, and agricultural biotechnology. He aims to enhance ONIT's research and development efforts and has already initiated field trials to optimize the company’s products for various applications, including cattle ranching. ONIT Sciences, founded in 2018, focuses on increasing crop yield and plant health through organic technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

PRT Growing Services Ltd., a leader in container-grown forest seedlings, has appointed Collin Phillip as Chief Commercial Officer and Marlene Higgins as Chief People Officer. These strategic hires are aimed at enhancing PRT’s position for future growth. Phillip brings a strong background in sales and supply chain from companies like Corteva Agriscience and The Monsanto Company, while Higgins has extensive HR experience from Structurlam. Together, they are expected to drive success in expanding PRT’s services and nurturing its workforce.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
management
-
Rhea-AI Summary

Bactobio Ltd, a London-based biotechnology firm, has successfully closed an oversubscribed £6 million bridge financing round led by Bridford Group. The round included notable supporters such as former executives from Novozymes and Monsanto, alongside new investors from fintech companies. The funds will enhance Bactobio's discovery pipeline and further its work in developing safer antimicrobial solutions from unexplored microbes. CEO Dr. Daniel Hansen expressed pride in the company's progress and continued support from high-caliber investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.65%
Tags
none
-
Rhea-AI Summary

Pivot Bio, a leader in nitrogen innovation, announced significant management changes to support its growth. Roger Underwood joins as independent director and Chairperson, bringing extensive ag tech experience. Lisa Safarian is promoted to President & COO, overseeing operations after leading Bayer's $9.5 billion North American crop science business. Evan Wittenberg is appointed as Chief People Officer, and Ernie Sanders is promoted to Senior VP of Product Innovation, focusing on expanding product offerings. These changes aim to enhance Pivot Bio's commitment to providing farmers with reliable nitrogen solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
management
Rhea-AI Summary

PPG has announced the appointment of Tim Knavish as the new President and CEO effective January 1, 2023. Knavish, who has served as COO since March, will succeed Michael McGarry, who transitions to Executive Chairman after leading the company since September 2015. The change is expected to enhance PPG's growth strategy amid current economic challenges. Knavish brings extensive experience from various leadership roles at PPG, which operates globally and reported $16.8 billion in net sales for 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Bayer Aktien (BAYRY)?

The current stock price of Bayer Aktien (BAYRY) is $13.61 as of February 10, 2026.

What is the market cap of Bayer Aktien (BAYRY)?

The market cap of Bayer Aktien (BAYRY) is approximately 33.2B.
Bayer Aktien

OTC:BAYRY

BAYRY Rankings

BAYRY Stock Data

33.21B
3.93B
0.59%
Drug Manufacturers - General
Healthcare
Link
Germany
Leverkusen

BAYRY RSS Feed